Abstract: An expandable tubular device is used as a stent for implantation in the lumen of a body duct, such as a blood vessel in particular, in order to ensure a passage therein, said device consisting of an assembly of tubular elements aligned along a common longitudinal axis and successively joined together in pairs by a plurality of linking members, each tubular element consisting of a strip forming a zigzag corrugation defining bent extreme portions which are successively connected together in pairs in opposite directions by rectilinear intermediate portions, the thickness (e) of said strip forming each of the above-mentions tubular elements (1), measured radially relative to said tubular element, being greater than the width 1 of this strip in said bent portions (2).

Abstract: The object of the present invention is a system for the treatment of a body duct, such as a blood vessel in particular, of the type comprising a stent forming element comprising a frame made from a material having a low elastic recovery capacity, which is intended, in the position of use, to restore and/or to maintain the normal passage cross-section of said duct to be treated, and an inflatable expanding element disposed in the interior relative to said stent forming element.

Abstract: The invention relates to novel fluorinated organic compounds having the following molecular structure: ##STR1## where R.sub.F is a fluorinated carbon chain, R.sub.1H is hydrogen or a saturated hydrogenated carbon chain, R.sub.2H is hydrogen or a saturated hydrogenated carbon chain, R.sub.1H and R.sub.2H being not simultaneously hydrogen, the group ##STR2## comprising a principal chain and at least one linear or cyclic branch. These compounds may be prepared by reacting a phosphine with a halide under heating, and then hot reacting in a solvent the resulting phosphonium salt with a branched aldehyde or a ketone. These compounds have an excellent stability, a good biocompatibility and a high capacity to solubilize gases and particularly oxygen, such properties allowing their use in applications of the ophthalmological type or as an organ preservation medium.

Abstract: A sclerotomy implant intended to be set in place in the sclera of the eye in order to provide for a continuous flow of aqueous humor through the trabecula for the treatment of a glaucoma. This implant is configured like a platelet made of biocompatible material and comprising an intrascleral portion (1) and a sub-conjuctival portion (5), the latter being adapted to come out of the sclera and penetrate under the conjunctiva. Retaining flanges (7a, 7b) provide for the blocking of the implant in the trap under the scleral flap. The implant comprises at least one continuous flow passage from its trabecular extremity (2) applied against the trabecula up to its external extremity (6) inserted in the conjunctiva.